This study extends the existing scientific evidence supporting the use of DSNS in T2DM and is the first study, to our knowledge, that provides data on the GLP-1 response to a high-protein, low-fat DSNS where protein appears to be the main driver of GLP-1 and insulin response. The gene discussed is INS; the disease is type 2 diabetes mellitus.